Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MACROGENICS INCMGNX · Entity 6104 | VP, Controller & Treasurer | February 12, 2026 | February 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MACROGENICS INC
Report date February 12, 2026 · Filed February 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,781 |
Ending reported balance
After 2026-02-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-02-15 · Exercise / conversion · Acquired 1,095 · Balance 13,204 F1: On February 15, 2023, the reporting person was granted 3,285 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. Row 2 · 2026-02-15 · Tax withholding · Disposed 423 · Balance 12,781 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-02-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-02-15 · Exercise / conversion · Disposed 1,095 · Balance 0 F1: On February 15, 2023, the reporting person was granted 3,285 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 15,625 |
Reported balance
After 2026-02-12 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-02-12 · Grant · Acquired 15,625 · Balance 15,625 F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.71 · Expires 2036-02-12 | Direct | 93,750 |
Reported balance
After 2026-02-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-12 · Grant · Acquired 93,750 · Balance 93,750 F3: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 15, 2023, the reporting person was granted 3,285 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis.
F2: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
F3: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 15, 2026 Filed Feb 17, 2026 23:26 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 1,095 | $0.00 | $0.00 |
DisclosureSEC source: 0002051299-26-000005 · wk-form4_1771370783.xml · derivative · entry 3 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 15, 2023, the reporting person was granted 3,285 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 15, 2023, the reporting person was granted 3,285 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 15, 2023, the reporting person was granted 3,285 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 23:26 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 423 | $1.71 | $723.33 |
DisclosureSEC source: 0002051299-26-000005 · wk-form4_1771370783.xml · nonDerivative · entry 2 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,781 Read SEC document |
| February 15, 2026 Filed Feb 17, 2026 23:26 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 1,095 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002051299-26-000005 · wk-form4_1771370783.xml · nonDerivative · entry 1 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 15, 2023, the reporting person was granted 3,285 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 23:26 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee Stock Option (right to buy) · Derivative | 93,750 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0002051299-26-000005 · wk-form4_1771370783.xml · derivative · entry 5 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,750 Underlying: Common Stock · 93,750 shares Expires 2036-02-12 F3 · derivative.exercise_date: 12.5% of the shares underlying the grant became exercisable one year after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 23:26 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 15,625 | $0.00 | $0.00 |
DisclosureSEC source: 0002051299-26-000005 · wk-form4_1771370783.xml · derivative · entry 4 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,625 Underlying: Common Stock · 15,625 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F2 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F2 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 23:16 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 1,583 | $0.00 | $0.00 |
DisclosureSEC source: 0002051299-26-000002 · wk-form4_1770765365.xml · derivative · entry 6 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,584 Underlying: Common Stock · 1,583 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into the Company's stock on a one-for-one basis. F3 · derivative.exercise_date: On February 8, 2024, the reporting person was granted 4,750 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On February 8, 2024, the reporting person was granted 4,750 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 23:16 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 612 | $1.81 | $1,107.72 |
DisclosureSEC source: 0002051299-26-000002 · wk-form4_1770765365.xml · nonDerivative · entry 4 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,109 Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 23:16 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 1,583 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002051299-26-000002 · wk-form4_1770765365.xml · nonDerivative · entry 3 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,721 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 23:16 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 2,617 | $0.00 | $0.00 |
DisclosureSEC source: 0002051299-26-000002 · wk-form4_1770765365.xml · derivative · entry 5 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,233 Underlying: Common Stock · 2,617 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into the Company's stock on a one-for-one basis. F2 · derivative.exercise_date: On February 7, 2025, the reporting person was granted 7,850 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. F2 · derivative.expiration_date: On February 7, 2025, the reporting person was granted 7,850 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 23:16 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 1,011 | $1.81 | $1,829.91 |
DisclosureSEC source: 0002051299-26-000002 · wk-form4_1770765365.xml · nonDerivative · entry 2 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,138 Read SEC document |
| February 07, 2026 Filed Feb 10, 2026 23:16 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 2,617 | Not disclosed | Not disclosed |
DisclosureSEC source: 0002051299-26-000002 · wk-form4_1770765365.xml · nonDerivative · entry 1 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,149 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:07 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $1.33 | $0.00 |
DisclosureSEC source: 0002051299-25-000004 · wk-form4_1765400846.xml · derivative · entry 1 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2035-12-08 F1 · derivative.exercise_date: 25% of the options will vest and become exercisable one year from the grant date and the remaining 75% will vest in 12 substantially equal quarterly installments thereafter Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:23 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 1,095 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-25-000031 · wk-form4_1740000190.xml · derivative · entry 3 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,095 Underlying: Common Stock · 1,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 15, 2023 the reporting person was granted 3,285 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 15, 2023 the reporting person was granted 3,285 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 15, 2023 the reporting person was granted 3,285 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:23 UTC | MACROGENICS INC MGNX · Entity 6104 | SaleCommon Stock | 423 | $2.56 | $1,082.88 |
DisclosureSEC source: 0001125345-25-000031 · wk-form4_1740000190.xml · nonDerivative · entry 2 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,532 Read SEC document |
| February 15, 2025 Filed Feb 19, 2025 21:23 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 1,095 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-25-000031 · wk-form4_1740000190.xml · nonDerivative · entry 1 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 15, 2023 the reporting person was granted 3,285 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 08, 2025 Filed Feb 12, 2025 01:29 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionRestricted Stock Unit · Derivative | 1,583 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001125345-25-000016 · wk-form4_1739323737.xml · derivative · entry 5 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,167 Underlying: Common Stock · 1,583 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 8, 2024 the reporting person was granted 4,750 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.exercise_date: On February 8, 2024 the reporting person was granted 4,750 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. F1 · derivative.expiration_date: On February 8, 2024 the reporting person was granted 4,750 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 08, 2025 Filed Feb 12, 2025 01:29 UTC | MACROGENICS INC MGNX · Entity 6104 | Tax withholdingCommon Stock | 612 | $2.60 | $1,591.20 |
DisclosureSEC source: 0001125345-25-000016 · wk-form4_1739323737.xml · nonDerivative · entry 2 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,860 Read SEC document |
| February 08, 2025 Filed Feb 12, 2025 01:29 UTC | MACROGENICS INC MGNX · Entity 6104 | Exercise / conversionCommon Stock | 1,583 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001125345-25-000016 · wk-form4_1739323737.xml · nonDerivative · entry 1 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On February 8, 2024 the reporting person was granted 4,750 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis. Read SEC document |
| February 07, 2025 Filed Feb 12, 2025 01:29 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantRestricted Stock Unit · Derivative | 7,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001125345-25-000016 · wk-form4_1739323737.xml · derivative · entry 4 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,850 Underlying: Common Stock · 7,850 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F3 · derivative.exercise_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. F3 · derivative.expiration_date: Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter. Read SEC document |
| February 07, 2025 Filed Feb 12, 2025 01:29 UTC | MACROGENICS INC MGNX · Entity 6104 | GrantEmployee Stock Option (right to buy) · Derivative | 47,050 | $0.00 Strike: $2.60 | $0.00 |
DisclosureSEC source: 0001125345-25-000016 · wk-form4_1739323737.xml · derivative · entry 3 Smith Beth Ann · CIK 0002051299 · VP, Controller & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,050 Underlying: Common Stock · 47,050 shares Expires 2035-02-07 F2 · derivative.exercise_date: 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.